Skip to main content
. 2017 Jan 18;8(9):14693–14707. doi: 10.18632/oncotarget.14711

Figure 1. MiR-744 was overexpressed in CRPC and positively associated with CRPC progression.

Figure 1

(A) Experimental scheme. (B) Expression levels of miR-744 was verified by qRT-PCR in CRPC and ADPC tissues (P < 0.001). U6 RNA was measured as an internal control. (C) Kaplan–Meier analysis of biochemical relapse-free survival for 98 patients with PCa (Data acquired from MSKCC (GSE21032)). Patients with high miR-744 expression had a lower survival rate than those with low miR-744 expression (P < 0.0001).